Seal vs Sapio Sciences

1Sapio and Seal, side by side.

Sapio and Seal are both configurable platforms with AI at the centre, and both version a process when it changes.¹ They are built around different work. Sapio describes its platform as AI-native, uniting LIMS and ELN for life sciences from research to clinical diagnostics and manufacturing, with its AI co-scientist, Elain, built in.² Seal configures laboratory, manufacturing and quality workflows on one platform around a shared ontology for GxP biopharma, so a QC result, its batch and the deviation or CAPA it leads to are records in the same system.

2What Sapio is built for.

Sapio is built for scientific organisations that want one configurable platform for research, development and testing, with AI assisting the scientist. Sapio Sciences was founded as a machine learning and AI company, and has its North American headquarters in Baltimore, Maryland, and its European headquarters in London.³ It is led by its founder and chief executive, Kevin Cramer.⁴

The platform combines Sapio LIMS, Sapio ELN and the Sapio Scientific Data Cloud, presents scientific data as a searchable knowledge graph, and includes tools for CRISPR editing, plasmid design, flow cytometry and 3D plating.⁵ The LIMS is configured with a drag-and-drop workflow builder, a rules engine written in English sentences and a configurable interface. It tracks samples from order to report with chain of custody and lineage, comes with cloud or on-premise options and pre-integrated instruments, and is described as ready for GLP, GCP and GMP compliance.⁶ Templated solutions cover biotech and chemistry research, multimodal registration, NGS, in vivo studies, bioanalysis, bioprocessing, antibody discovery and clinical diagnostics with a physician portal.²

For GMP work, Sapio offers a QC LIMS with product registration, batch creation, automatic sampling plans, pre-configured assays and acceptance criteria, automatic pass or fail and certificates of analysis and release with electronic signature; environmental monitoring with test plans generated by AI from site images; and stability studies with time points, automatic test requests, trend analysis and shelf-life projections. Sapio says these solutions comply with 21 CFR Part 11 and EU Annex 11.⁷ Sapio EBR adds no-code batch record templates, executor and inspector roles, material and equipment tracking, in-process control, automatic submission of completed batches for QC review, an immutable audit log and documentation of deviations and corrective actions.⁸ Sapio holds SOC 2 Type II and ISO 27001, and is certified for French health data hosting (HDS).⁹

3How a QC method change is released.

Both platforms release a method as a versioned process with recorded approvals. Seal also keeps the acceptance tests and their results with each change.

Sapio’s QC LIMS lets scientists compose an assay process from more than 18 published experiment templates, arranged into unit operations. Fields are discovered from the templates; scientists flag critical specifications, set acceptance limits and pick lists, and add warning ranges that flag drift at entry, for example acceptance at 280–320 with a warning at 270–330. Reporting rules set limits such as NMT, value-dependent precision and rounding. Publication needs two electronic signatures from different approvers, and produces an immutable version: published versions are view-only, and a change produces the next version. Sapio’s page walks through a metformin hydrochloride release test, from draft to frozen version.¹

In Seal, a new or revised method is prepared as a changeset that carries the requirement, the configuration and its verification. In the example in Seal’s LIMS blueprint, Neil proposes a potency release test from the approved method and specification. Your team checks the preparation calculation, the required system-suitability records and the assigned limits against the source, and tests that an outside-limit result follows the investigation route and that missing evidence prevents completion. When the changeset is prepared for review, its selected acceptance tests run, and publication requires current passing results. Failures, corrections and retests stay with the candidate revision, and runs on the earlier version keep the version they used.

What follows the release also differs. In Seal, an outside-limit result opens an investigation on the same records as the sample, method and batch, and the investigation can lead to a CAPA and a change to the workflow under Seal’s quality workflows. To compare the two in practice, take one limit change through each, including a failed test and its retest, and inspect the evidence that remains afterwards.

4Two approaches to AI in the laboratory.

Both companies put AI at the centre of the product. They point it at different jobs.

Sapio presents Elain as an AI co-scientist for research. Scientists build experiments in natural language, and AI agents execute, analyse and document the work, with cheminformatics, bioinformatics and structure-based design built in. A partner ecosystem brings models and tools from AWS, NVIDIA, Cadence OpenEye, the CCDC, Optibrium, Schrödinger, Simulations Plus, Elsevier and MedBioInformatics into the same prompt.¹⁰ In QC, ELaiN turns a one-sentence prompt into analyses such as pass or fail heatmaps and per-batch statistics, can schedule and email them, and works with Claude, Copilot, ChatGPT and Gemini; Sapio says each request is access-controlled and logged.¹

Neil is Seal’s AI agent for GxP work. It works across permitted records and connected systems with the requester’s permissions, and what it produces is work in the system: a proposed workflow, an assembled investigation brief or a prepared configuration change. People approve, Neil never releases a change on its own, customer data is not used to train AI models under Seal’s agreements, and AI can be switched off for the whole organisation. In line with the EU’s draft GMP Annex 22 on AI, Neil is not used in GMP execution. It helps set up configuration, which your team verifies and releases under change control.

5Where Sapio is the better fit.

Sapio is the better fit when research is the centre of gravity and you want one platform from discovery onwards.

• You want LIMS and ELN on one platform across chemistry, multimodal registration, NGS, in vivo, bioanalysis and bioprocessing.²
• Your scientists want built-in tools for CRISPR editing, plasmid design and flow cytometry.⁵
• You want an AI co-scientist connected to molecular modelling, literature and disease-genomics partners.¹⁰
• Your QC scientists should compose their own assays from reusable templates, with dual-signature publication.¹
• You run clinical or molecular diagnostics and want a physician order portal on the same platform.²
• You need an on-premise option.⁶

6Where Seal is the better fit.

Seal is the better fit when GxP laboratory, manufacturing and quality work should change together.

• Your deviations, CAPA, change control, document control and training should run on the same records as the laboratory and the batch, so a corrective action can be released as a verified change to the workflow and measured on the runs that follow.
• You want each change to carry its requirements, specifications, acceptance tests and approvals, with publication requiring current passing results.
• You want specifications as versioned records, with each result keeping the version it was evaluated against.
• You want an AI agent scoped to preparing configuration, investigations and changes for qualified people to approve.

7Running Seal alongside Sapio.

A common split is research and development in Sapio and one GMP process in Seal. Seal has no dedicated Sapio connector. Where a system is not on Seal’s integrations list, Seal’s REST API and Scripts can connect it, and Seal can review its interfaces with you.

Confirm with Sapio which interfaces your deployment exposes, and agree the records, the direction of transfer, the credentials and the failure handling before setting up the connection. Scripts are versioned Python in Seal that can call an external service after an event or on a schedule; they are edited in a changeset, tested and published like other Seal records. Start with read access: for example, bring the development evidence behind an approved method into Seal so it stays with the method version QC runs. Keep the Sapio identifier on the linked Seal record rather than creating a second identity, and treat any write-back as a separate decision with its own controls. The regulatory guide covers how to qualify the connection.

8Moving from Sapio to Seal.

Move one GMP process first. Research can stay in Sapio.

1. Choose one release test, stability study or incoming-inspection workflow where results should feed batch disposition and quality decisions.
2. Bring the approved method or protocol, a redacted specification, a representative result and an instrument export. Start with sample material, or arrange an NDA before sharing confidential records.
3. Neil proposes the workflow, and your team checks it against the source. Once the scope is agreed and the inputs received, Seal prepares the first working process and its validation pack within 48 hours. Production timing then depends on scope, interfaces, migration and your release requirements.
4. Exercise the failure cases before release: an outside-limit result, missing evidence, an unapproved method version and an incomplete review.
5. Agree which system owns each record during the transition and what must reconcile. Evaluate historical records, original files, versions and review status before deciding what to migrate; work outside the scope stays in Sapio.

The LIMS blueprint and the ELN blueprint describe the laboratory workflows in detail.